CRISPR gene-editing corrects muscular dystrophy in pigs

Duchenne muscular dystrophy (DMD) is one of the most common and most devastating muscular diseases, greatly reducing patients’ quality of life and life expectancy. Now, researchers in Germany have managed to use the CRISPR gene-editing tool to correct the condition in pigs, bringing the treatment ever closer to human trials.
Read more: https://newatlas.com/medical/crispr-gene-editing-muscular-dystrophy-pigs/?source=Snapzu